Skip to main content

Table 6 Plaintiffs’ incomes, cost of medicines of the lawsuits, origin of the prescription and classification of medicines in the lawsuits in periods before and after the deployment of the Department of Assessment of Non-Standardized Medicines (DAMNP) and Technical Chamber of Health Assessment (CATS)

From: Institutional strategies as a mechanism to rationalize the negative effects of the judicialization of access to medicine in Brazil

VariablesDAMNP (2006) CATS (2009) 
Before deployment (2003–2005)After deployment (2007–2015)pBefore deployment (2003–2008)After deployment (2010–2015)p
Income of Plaintiffs
 Mean (SD)11231.4 (858.7)1458.2 (1182.8)0.00931393.4 (999.8)1458.2 (1215.2)0.5753
 Median (IQR)21004.5 (680.5–1263.8)1137.8 (680.5–1263.8) 1004.5 (680.5–1263.8)972.1 (680.5–1263.8) 
Cost of medicines in the lawsuit
 Mean (SD)11.661.1 (4.561.7)779.2 (1.589.6)0.00531.884.1 (5.054.8)586.7 (1.640.3)<  0.0013
 Median (IQR)2659.7 (188.6–1622.1)285.6 (101.0–195.8) 541.1 (191.6–1759.4)250.3 (94.5–616.3) 
Prescription’s origin, n (%)
 Prescribed by a SUS clinician20 (25.6)38 (31.4)0.382446 (22.4)24 (43.6)0.0024
 Prescribed by a private system clinician58 (74.4)83 (68.6) 159 (77.6)31 (56.4) 
Classification of medicines, n (%)
 Within the SUS formulary261 (47.7)281 (41.8)0.0394548 (49.5)104 (41.1)0.0204
 Outside the SUS formulary with a therapeutic alternative145 (26.5)217 (32.3)0.0284289 (26.1)94 (37.2)<  0.0014
 Outside the SUS formulary without a therapeutic alternative141 (25.8)174 (25.9)0.9634271 (24.4)554 (21.7)0.3604
  1. 1Standard deviation; 2Interquartile range; 3Mann-Whitney Test; 4Pearson’s chi-squared test